文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

探索脓毒症小鼠模型中的肥胖悖论:肥胖小鼠器官损伤更重但生存率更高

Exploring the Obesity Paradox in A Murine Model of Sepsis: Improved Survival Despite Increased Organ Injury in Obese Mice.
PubMed 文献 · Shock · 2022-01-01
一句话结论高脂饮食诱导的肥胖脓毒症小鼠14天生存率更高(66% vs 25%,P=0.01),但细菌培养阳性率和肾损伤标志物也更高。

本研究用高脂饮食(HFD)或低脂饮食(LFD)喂养雄性C57BL/6小鼠20周,以盲肠浆液(CS)注射诱导脓毒症,检验肥胖悖论是否存在。HFD组14天生存率显著高于LFD组(66% vs 25%,P=0.01),但HFD组细菌培养阳性率和肾损伤标志物更高。CS注射后24小时两组IL-6、IL-1β、TNFα、IL-23水平相当,但IL-17A仅在HFD组升高。HFD组在CS注射后6和12小时呈高血糖,而LFD组维持正常血糖;肝脏稳定同位素代谢组学显示两组葡萄糖利用途径出现分歧。该小鼠研究印证了临床中肥胖带来脓毒症生存获益但以更重器官损伤为代价的现象,机制尚不明确。

要点

  • 高脂饮食诱导肥胖小鼠在CS诱导脓毒症后14天生存率66%,显著高于低脂饮食小鼠的25%(P=0.01)。
  • 尽管生存率更高,HFD组细菌培养阳性率和肾损伤标志物均高于LFD组,提示生存获益以更重器官损伤为代价。
  • CS注射后24小时两组IL-6、IL-1β、TNFα、IL-23水平相当,但IL-17A仅在HFD组特异性升高。
  • HFD组在CS注射后6和12小时呈高血糖,而LFD组维持正常血糖。
  • 肝脏代谢组学显示脓毒症期间LFD组显著上调糖酵解活性,而HFD组减少葡萄糖进入TCA循环。

适用人群与场景

  • 雄性C57BL/6小鼠,接受高脂饮食或低脂饮食20周后以盲肠浆液(CS)注射诱导脓毒症;非人类临床研究,适用人群与场景原文未提及。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为小鼠实验研究;样本量、中心数原文未提及;人群为雄性C57BL/6小鼠,高脂饮食(HFD)或低脂饮食(LFD)喂养20周后以盲肠浆液(CS)注射诱导脓毒症。
  • 主要终点结果:HFD组14天生存率66%,LFD组25%,P=0.01(生存评估14天)。
  • HFD组细菌培养阳性率和肾损伤标志物高于LFD组;CS注射后24小时IL-6、IL-1β、TNFα、IL-23水平两组相当,IL-17A仅在HFD组升高。
  • HFD组CS注射后6和12小时高血糖,LFD组维持正常血糖;肝脏稳定同位素代谢组学显示LFD组显著上调糖酵解活性,HFD组减少葡萄糖进入TCA循环。

证据类型、等级与局限

  • 证据类型为动物实验研究;原文未给出证据等级或推荐强度;局限包括种属差异(小鼠模型)、样本量未报告、机制尚未明确。

对床旁实践的改变

  • 原文未提及对急诊或ICU具体实践的改变;该小鼠模型可能为研究肥胖脓毒症生存悖论的机制提供工具,但尚不能直接改变临床做法。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Despite the known deleterious effects of obesity, clinical data indicate that overweight or obese patients experience higher rates of sepsis survival compared to normal and underweight patients; a phenomenon called the obesity paradox. Results from preclinical sepsis studies have not been able to replicate these findings. The objective of this study was to test the existence of the obesity paradox in a murine model of cecal slurry (CS)-induced sepsis with insulin-resistant diet-induced obese mice. Male C57BL/6 mice were provided high-fat (HFD) or low-fat (LFD) diets for 20 weeks. HFD-fed mice experienced higher rates of survival compared to LFD-fed mice after septic challenge induced by CS injection (66% vs. 25%, P = 0.01, survival assessed for 14 days). Despite the survival advantage, HFD-fed mice had higher rates of positive bacterial cultures and increased markers of kidney injury. Circulating levels of IL-6, IL-1β, TNFα, and IL-23 were equivalent 24 h after CS-injection; however, IL-17A was uniquely increased in HFD-fed mice. While LFD-fed mice maintained euglycemia, HFD-fed mice were hyperglycemic 6 and 12 h after CS-injection. Stable isotope resolved metabolomics analysis of liver tissue showed diverging pathways of glucose utilization during sepsis, with LFD-fed mice significantly upregulating glycolytic activity and HFD-fed mice decreasing glucose entry into the TCA cycle. This murine study corroborates clinical data that obesity confers a survival benefit in sepsis, albeit at the expense of more significant organ injury. The mechanisms promoting survival in the obese remain unknown; however, this model appears to be well-poised to begin answering this question. Differences in glucose utilization are a novel target to investigate this paradox.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lewis ED, Williams HC, Bruno MEC, et al. Exploring the Obesity Paradox in A Murine Model of Sepsis: Improved Survival Despite Increased Organ Injury in Obese Mice. Shock. 2022. PMID: 34482320. doi:10.1097/SHK.0000000000001856

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。